BRPI0815358A2 - Compostos 2-(2-oxoindolina-3-ilideno)metil-5-(2-hidróxi-3-morfoli n-4-il-propil)-6,7-di-hidro-1h-pirrol[3,2-c]piridina-4(5h)- ona e uso como inibidores de proteínoquinase - Google Patents

Compostos 2-(2-oxoindolina-3-ilideno)metil-5-(2-hidróxi-3-morfoli n-4-il-propil)-6,7-di-hidro-1h-pirrol[3,2-c]piridina-4(5h)- ona e uso como inibidores de proteínoquinase

Info

Publication number
BRPI0815358A2
BRPI0815358A2 BRPI0815358-2A2A BRPI0815358A BRPI0815358A2 BR PI0815358 A2 BRPI0815358 A2 BR PI0815358A2 BR PI0815358 A BRPI0815358 A BR PI0815358A BR PI0815358 A2 BRPI0815358 A2 BR PI0815358A2
Authority
BR
Brazil
Prior art keywords
oxydoline
propil
ilidene
morpholi
pyrol
Prior art date
Application number
BRPI0815358-2A2A
Other languages
English (en)
Inventor
Jialiang Yang
Yidong Su
Fuqiang Zhao
Peng Cho Tang
Original Assignee
Shanghai Hengrui Pharm Co Ltd
Jiangsu Hengrui Medicine Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Hengrui Pharm Co Ltd, Jiangsu Hengrui Medicine Co filed Critical Shanghai Hengrui Pharm Co Ltd
Publication of BRPI0815358A2 publication Critical patent/BRPI0815358A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BRPI0815358-2A2A 2007-08-15 2008-07-29 Compostos 2-(2-oxoindolina-3-ilideno)metil-5-(2-hidróxi-3-morfoli n-4-il-propil)-6,7-di-hidro-1h-pirrol[3,2-c]piridina-4(5h)- ona e uso como inibidores de proteínoquinase BRPI0815358A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2007101418749A CN101367801B (zh) 2007-08-15 2007-08-15 吡咯并六元n杂环羟基吗啡啉类衍生物的制备方法及其在医药上的应用
PCT/CN2008/001388 WO2009024016A1 (fr) 2007-08-15 2008-07-29 Composés de 2-(2-oxoindoline-3-ylidène)méthyl-5-(2-hydroxy-3-morpholin-4-yl-propyl)-6,7-dihydro-1h-pyrrol[3,2-c]pyridine-4(5h)-one et utilisation en tant qu'inhibiteurs de protéine kinase

Publications (1)

Publication Number Publication Date
BRPI0815358A2 true BRPI0815358A2 (pt) 2015-02-10

Family

ID=40377816

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0815358-2A2A BRPI0815358A2 (pt) 2007-08-15 2008-07-29 Compostos 2-(2-oxoindolina-3-ilideno)metil-5-(2-hidróxi-3-morfoli n-4-il-propil)-6,7-di-hidro-1h-pirrol[3,2-c]piridina-4(5h)- ona e uso como inibidores de proteínoquinase

Country Status (14)

Country Link
US (1) US8299069B2 (pt)
EP (1) EP2179998B1 (pt)
JP (1) JP2010535819A (pt)
KR (1) KR20100059869A (pt)
CN (1) CN101367801B (pt)
AU (1) AU2008288615B2 (pt)
BR (1) BRPI0815358A2 (pt)
CA (1) CA2694380A1 (pt)
MX (1) MX2010001602A (pt)
RU (1) RU2472792C2 (pt)
TW (1) TW201000100A (pt)
UA (1) UA98797C2 (pt)
WO (1) WO2009024016A1 (pt)
ZA (1) ZA201000627B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5256047B2 (ja) 2006-01-27 2013-08-07 シャンハイ ヘンルイ ファーマシューティカル カンパニー リミテッド ピロロ［３，２−ｃ］ピリジン−４−オン２−インドリノン（ｉｎｄｏｌｉｎｏｎｅ）プロテインキナーゼ阻害剤
US8697697B2 (en) 2011-01-04 2014-04-15 Kinentia Biosciences Llc Pyrazole derivatives as ERK inhibitors
CN104109160B (zh) * 2013-04-17 2017-12-15 上海翰森生物医药科技有限公司 吡咯并n杂环类化合物及其制备方法和医药用途
CN106565585A (zh) * 2016-10-13 2017-04-19 云南大学 一种n‑取代亚苄基吡咯烷二酮及其制备方法和用途
CN114057735B (zh) * 2020-08-03 2024-02-20 江苏恒瑞医药股份有限公司 一种多靶点酪氨酸激酶抑制剂的新晶型及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9423997D0 (en) * 1994-11-28 1995-01-11 Erba Carlo Spa Substituted 3-arylidene-7-azaoxindole compounds and process for their preparation
ATE297395T1 (de) * 2000-02-28 2005-06-15 Sugen Inc 3-(pyrolyllacton)-2-indolinon verbindungen zur verwendung als kinase-hemmstoffe
CA2410509A1 (en) * 2000-06-02 2001-12-13 Sugen, Inc. Indolinone derivatives as protein kinase/phosphatase inhibitors
WO2002002551A1 (en) * 2000-06-30 2002-01-10 Sugen, Inc. 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors
CN1511151A (zh) * 2001-05-24 2004-07-07 ֮����ҩ��ʽ���� 3-喹啉-2(1h)-亚基二氢吲哚-2-酮衍生物
US20040209937A1 (en) 2003-02-24 2004-10-21 Sugen, Inc. Treatment of excessive osteolysis with indolinone compounds
CN101007815B (zh) * 2006-01-27 2010-06-23 江苏恒瑞医药股份有限公司 吡咯并六元杂环化合物及其在医药上的用途
CN101007814A (zh) * 2006-01-27 2007-08-01 上海恒瑞医药有限公司 吡咯并六元杂环化合物及其在医药上的用途
JP5256047B2 (ja) * 2006-01-27 2013-08-07 シャンハイ ヘンルイ ファーマシューティカル カンパニー リミテッド ピロロ［３，２−ｃ］ピリジン−４−オン２−インドリノン（ｉｎｄｏｌｉｎｏｎｅ）プロテインキナーゼ阻害剤
RU2302417C1 (ru) * 2006-03-14 2007-07-10 Иващенко Андрей Александрович 1-оксо-3-(1н-индол-3-ил)-1,2,3,4-тетрагидроизохинолины, способы их получения, комбинаторная библиотека и фокусированная библиотека

Also Published As

Publication number Publication date
TW201000100A (en) 2010-01-01
JP2010535819A (ja) 2010-11-25
CN101367801A (zh) 2009-02-18
EP2179998A4 (en) 2010-07-28
UA98797C2 (en) 2012-06-25
AU2008288615B2 (en) 2013-01-10
AU2008288615A1 (en) 2009-02-26
KR20100059869A (ko) 2010-06-04
EP2179998A1 (en) 2010-04-28
RU2010104752A (ru) 2011-09-20
MX2010001602A (es) 2010-03-15
CN101367801B (zh) 2011-01-12
US20100160317A1 (en) 2010-06-24
CA2694380A1 (en) 2009-02-26
US8299069B2 (en) 2012-10-30
ZA201000627B (en) 2011-04-28
RU2472792C2 (ru) 2013-01-20
EP2179998B1 (en) 2012-08-29
WO2009024016A1 (fr) 2009-02-26

Similar Documents

Publication Publication Date Title
CY2020006I1 (el) Ενωσεις υποκατεστημενης πυραζολο [1,5-] πυριμιδινης ως αναστολεις κινασης trk
CU23886B1 (es) Derivados de pirrolo [2,3-d] pirimidina como inhibidores de proteínas quinasas b
DK2229391T3 (da) Pyrido[2,3-B]pyrazin-8-substituerede forbindelser og deres anvendelse
BRPI0722088A2 (pt) derivados de pirrolo[2,3-b]piridina como moduladores de cinase
HK1220455A1 (zh) 嘧啶取代的大環抑制劑
BRPI0809998A2 (pt) Composto de imidazo[1,2-a] piridina como inibidores do receptor tirosina cinase
BRPI0908433A2 (pt) pirrolo[2,3-d]piridinas e empregos destas como inibidores tirosina cinase
BRPI0919948A2 (pt) Pirido[4,3-b]indois contendo porções rígidas
BRPI0809974A2 (pt) Compostos de pirimidina hidrazida como inibidores de pgds
ATE471939T1 (de) Heterocyclische spiro-verbindungen als aldosteronsynthaseinhibitoren
BRPI0813831A2 (pt) Compostos de heteroarila bicíclica e seu uso como inibidores de quinase
DK2384326T3 (da) Pyrrolo[2,3-d]pyrimidinforbindelser
BRPI0911688A2 (pt) "compostos de pirimidina, composições e métodos de uso"
IL196775A0 (en) 2 - METHYLMORPHOLINE PYRIDO-PYRAZO - AND PYRIMIDO -, PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
ATE498625T1 (de) Heterocyclische spiro-verbindungen als aldosteronsynthaseinhibitoren
SI1966202T1 (sl) S heteroarilom substituirani pirolo (2,3-b)piridini in pirolo (2,3-b)pirimidini kot zaviralci janus kinaze
BRPI0714291A2 (pt) Derivados de [4,5']bipirimidinil-6-4'-diamina como inibidores de proteína cinase
DK1973910T3 (da) Pyrrolo[3,2-c]pyridin-4-on-2-indolinon-proteinkinaseinhibitorer
BR112012028519A2 (pt) compostos de 2,5,6,7-tetrahidro-[1,4]oxazepin-3-ilamina ou 2,3,6,7-tetrahidro-[1,4]oxazepin-5-ilamina
BR112012002110A2 (pt) derivados de pirrolo[1,2-b]piridazina como inibidores de janus cinase
BRPI0914544A2 (pt) derivados de pirimidona substituídos
BRPI0921598A2 (pt) derivados de piridina e pirimidina como inibidores de fosfodiesterase 10
BRPI0914301A2 (pt) derivados de pirimidin-4-ona substituída
IL211136A0 (en) Pyrido [5,4-d] pyrimidines as cell proliferation inhibitors
BRPI0815948A2 (pt) "compostos heterocíclicos como antagonistas de receptorncrth2"

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2385 DE 20-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.